Search

Your search keyword '"Njouendou AJ"' showing total 49 results

Search Constraints

Start Over You searched for: Author "Njouendou AJ" Remove constraint Author: "Njouendou AJ" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
49 results on '"Njouendou AJ"'

Search Results

1. Mouse models of Loa loa

2. Short-course, oral flubendazole does not mediate significant efficacy against Onchocerca adult male worms or Brugia microfilariae in murine infection models

3. Epidemiology of Newcastle disease virus among local chickens of west and south-west regions in Cameroon

4. Survival and growth of M. perstans larvae in a human colon carcinoma cell line-based in vitro culture.

5. Comparative development of human filariae Loa loa, Onchocerca volvulus and Mansonella perstans in immunocompromised mouse strains.

6. Impact of repeated mass ivermectin administration using a community directed approach on L . loa infection in Chrysops silacea of the rain forest and forest savanna of Cameroon.

7. Phenotypical characterization, and antibiotics susceptibility patterns of skin bacteria found in podoconiosis patients in the North West Region of Cameroon.

8. Concordance between Ov16 Rapid Diagnostic Test(RDT) and Ov16 Enzyme-Linked Immunosorbent Assay (ELISA) for the Diagnosis of Onchocerciasis in Areas of Contrasting Endemicity in Cameroon.

9. SOX2 dosage sustains tumor-promoting inflammation to drive disease aggressiveness by modulating the FOSL2/IL6 axis.

10. Application of loop mediated isothermal amplification (LAMP) assays for the detection of Onchocerca volvulus , Loa loa and Mansonella perstans in humans and vectors.

11. Molecular characterization of early breast cancer onset to understand disease phenotypes in African patients.

12. The preparatory phase for ground larviciding implementation for chocerciasis control in the Meme River Basin in South West Cameroon: the COUNTDOWN Consortium alternative strategy implementation trial.

13. Caregiver´s perception of the home-based management of childhood malaria in Baneghang and Fombap health areas in the West Region of Cameroon.

14. Onchocerca ochengi male worms implanted in SCID mice and Gerbil: Relationship between microfilaridermia status of cows, nodular worm viability and fertility and worm survival in the rodents.

15. Urine metabolites for the identification of Onchocerca volvulus infections in patients from Cameroon.

16. [Evaluation of two COVID-19 antigenic diagnostic tests: BIOSYNEX ® COVID-19 Ag BSS and BIOSYNEX ® COVID-19 Ag + BSS compared to AmpliQuick ® SARS-CoV-2 PCR ].

17. Comparative analysis of two molecular tests for the detection of COVID-19 in Cameroon.

18. Antibacterial, antifungal and antioxidant activities of whole plant chemical constituents of Rumex abyssinicus.

19. Establishment of an in vitro culture system to study the developmental biology of Onchocerca volvulus with implications for anti-Onchocerca drug discovery and screening.

20. The Mbam drainage system and onchocerciasis transmission post ivermectin mass drug administration (MDA) campaign, Cameroon.

21. Correction to: Differential susceptibility of Onchocerca volvulus microfilaria to ivermectin in two areas of contrasting history of mass drug administration in Cameroon: relevance of microscopy and molecular techniques for the monitoring of skin microfilarial repopulation within six months of direct observed treatment.

22. Validation of loop-mediated isothermal amplification for the detection of Loa loa infection in Chrysops spp in experimental and natural field conditions.

23. Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon.

24. Clinical, haematological and biochemical profiling of podoconiosis lymphoedema patients prior to their involvement in a clinical trial in the Northwest Region of Cameroon.

25. Differential susceptibility of Onchocerca volvulus microfilaria to ivermectin in two areas of contrasting history of mass drug administration in Cameroon: relevance of microscopy and molecular techniques for the monitoring of skin microfilarial repopulation within six months of direct observed treatment.

26. Generation of Loa loa infective larvae by experimental infection of the vector, Chrysops silacea.

27. Complete Mitochondrial Genome Sequence of Mansonella perstans .

28. Mapping lymphatic filariasis in Loa loa endemic health districts naïve for ivermectin mass administration and situated in the forested zone of Cameroon.

29. Comparison of immune responses to Loa loa stage-specific antigen extracts in Loa loa-exposed BALB/c mice upon clearance of infection.

30. Effects of an injectable long-acting formulation of ivermectin on Onchocerca ochengi in zebu cattle.

31. Dataset on in vitro maintenance of Mansonella perstans microfilariae and drug testing.

32. Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocol.

33. In vitro maintenance of Mansonella perstans microfilariae and its relevance for drug screening.

34. Depressive Symptoms Amongst People with Podoconiosis and Lower Limb Lymphoedema of Other Cause in Cameroon: A Cross-Sectional Study.

35. Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infections.

36. Update on the biology and ecology of Culicoides species in the South-West region of Cameroon with implications on the transmission of Mansonella perstans.

37. Preclinical development of an oral anti- Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasis.

38. Mapping of lymphatic filariasis in loiasis areas: A new strategy shows no evidence for Wuchereria bancrofti endemicity in Cameroon.

39. Effect of flubendazole on developing stages of Loa loa in vitro and in vivo: a new approach for screening filaricidal agents.

40. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.

41. Study of lymphoedema of non-filarial origin in the northwest region of Cameroon: spatial distribution, profiling of cases and socio-economic aspects of podoconiosis.

42. Predicted distribution and burden of podoconiosis in Cameroon.

43. Evaluation of in vitro culture systems for the maintenance of microfilariae and infective larvae of Loa loa.

44. Heterogeneity in the in vitro susceptibility of Loa loa microfilariae to drugs commonly used in parasitological infections.

45. Mansonella perstans microfilaremic individuals are characterized by enhanced type 2 helper T and regulatory T and B cell subsets and dampened systemic innate and adaptive immune responses.

46. Successful long-term maintenance of Mansonella perstans in an in vitro culture system.

47. Detecting and staging podoconiosis cases in North West Cameroon: positive predictive value of clinical screening of patients by community health workers and researchers.

48. Further evidence of the cross-reactivity of the Binax NOW® Filariasis ICT cards to non-Wuchereria bancrofti filariae: experimental studies with Loa loa and Onchocerca ochengi.

49. Cross-Reactivity of Filariais ICT Cards in Areas of Contrasting Endemicity of Loa loa and Mansonella perstans in Cameroon: Implications for Shrinking of the Lymphatic Filariasis Map in the Central African Region.

Catalog

Books, media, physical & digital resources